Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results o
Cognito Therapeutics to Present New Data for Spectris™ in Alzheimer’s D
Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results o
Cognito Therapeutics to Present New Data for Spectris™ in Alzheimer’s D